VeraBank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Sell
2,768
-250
-8% -$253K 0.47% 33
2025
Q4
$3.24M Sell
3,018
-71
-2% -$67.9K 0.59% 27
2025
Q3
$2.36M Hold
3,089
0.44% 41
2025
Q2
$2.41M Buy
3,089
+150
+5% +$117K 0.48% 39
2025
Q1
$2.43M Sell
2,939
-750
-20% -$624K 0.68% 29
2024
Q4
$2.85M Buy
3,689
+23
+0.6% +$19K 0.8% 26
2024
Q3
$3.25M Sell
3,666
-3
-0.1% -$2.7K 0.95% 22
2024
Q2
$3.32M Sell
3,669
-10
-0.3% -$8K 1.03% 22
2024
Q1
$2.86M Sell
3,679
-146
-4% -$104K 0.89% 25
2023
Q4
$2.23M Buy
3,825
+78
+2% +$45.5K 0.75% 30
2023
Q3
$2.01M Buy
3,747
+70
+2% +$36.1K 0.77% 29
2023
Q2
$1.72M Hold
3,677
0.66% 40
2023
Q1
$1.26M Sell
3,677
-32
-0.9% -$10.8K 0.59% 44
2022
Q4
$1.36M Hold
3,709
0.68% 37
2022
Q3
$1.2M Hold
3,709
0.76% 36
2022
Q2
$1.2M Sell
3,709
-34
-0.9% -$10.2K 0.7% 38
2022
Q1
$1.07M Sell
3,743
-39
-1% -$10K 0.55% 44
2021
Q4
$1.04M Buy
3,782
+236
+7% +$59.8K 0.53% 45
2021
Q3
$819K Buy
3,546
+88
+3% +$21.7K 0.46% 53
2021
Q2
$794K Buy
3,458
+58
+2% +$11.7K 0.47% 48
2021
Q1
$635K Hold
3,400
0.41% 58
2020
Q4
$574K Hold
3,400
0.4% 60
2020
Q3
$503K Hold
3,400
0.39% 61
2020
Q2
$558K Hold
3,400
0.46% 54
2020
Q1
$472K Buy
3,400
+1,500
+79% +$206K 0.46% 56
2019
Q4
$250K Buy
+1,900
New +$220K 0.2% 91

Other funds holding LLY

VeraBank's LLY Position: Q1 2026 in Review

VeraBank reduced its Eli Lilly (LLY) stake by 8.3% in Q1 2026, selling an estimated $253K and leaving 2,768 shares worth $2.55M. The position accounts for 0.47% of the portfolio, ranked #33.

VeraBank first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.32M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • VeraBank held 2,768 shares of Eli Lilly worth $2.55M as of Q1 2026.
  • VeraBank sold 250 Eli Lilly shares in Q1 2026, an estimated $253K.
  • Eli Lilly made up 0.47% of VeraBank's portfolio in Q1 2026, its #33 holding.
  • VeraBank first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • VeraBank's Eli Lilly position peaked at $3.32M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on VeraBank's 13F filing for Q1 2026, filed 12 May 2026.